Point72 Hong Kong’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-817
Closed -$1K 2548
2022
Q2
$1K Buy
+817
New +$720 ﹤0.01% 1840
2022
Q1
Sell
-16,752
Closed -$21K 2475
2021
Q4
$21K Buy
+16,752
New +$30K ﹤0.01% 1537
2021
Q3
Sell
-3,755
Closed -$14K 2563
2021
Q2
$14K Buy
3,755
+2,816
+300% +$9.79K ﹤0.01% 1697
2021
Q1
$3K Buy
+939
New +$3.37K ﹤0.01% 1697
2020
Q1
Sell
-3,956
Closed -$14K 1468
2019
Q4
$14K Buy
3,956
+3,176
+407% +$25.7K ﹤0.01% 946
2019
Q3
$6K Buy
+780
New +$6.31K ﹤0.01% 803
2019
Q2
Sell
-436
Closed -$5K 1477
2019
Q1
$5K Buy
+436
New +$4.67K ﹤0.01% 825

Other funds holding SPPI

Point72 Hong Kong's SPPI Position: Q3 2022 in Review

Point72 Hong Kong sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2022, closing a stake of 817 shares — an estimated $1K sold.

Point72 Hong Kong first reported a position in SPPI in Q1 2019 and held it in 7 quarters. The position peaked at $21K in Q4 2021. 75 funds tracked by Wall St. Rank hold SPPI as of Q3 2022.

  • Point72 Hong Kong reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 817 Spectrum Pharmaceuticals Inc shares in Q3 2022, an estimated $1K.
  • Point72 Hong Kong first reported a position in Spectrum Pharmaceuticals Inc in Q1 2019 and held it in 7 quarters.
  • Point72 Hong Kong's Spectrum Pharmaceuticals Inc position peaked at $21K in Q4 2021.
  • 75 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2022.

Based on Point72 Hong Kong's 13F filing for Q3 2022, filed 14 Nov 2022.